Regulation of Fas and FasL expression on rat Schwann cells

GLIA

Volumn 30, Issue 4, 2000, Pages 373-381

  Wohlleben, Gisela ^a   Ibrahim, Saleh M ^a,b   Schmidt, Jens ^a   Toyka, Klaus V ^a   Hartung, Hans Peter ^a,c   Gold, Ralf ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b UNIVERSITY OF ROSTOCK   (Germany)

^c UNIVERSITY OF GRAZ   (Austria)

Author keywords

Autoimmunity; Cytokine; Peripheral nervous system

Indexed keywords

EID: 0034127846     PISSN: 08941491     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1098-1136(200006)30:4<373::aid-glia60>3.0.co;2-%23     Document Type: Article

References (39)

1. + T-cell lines. J Neuroimmunol 40:1-18.
2. + T-cell lines on Lewis rat Schwann cells. J Neuroimmunol 40:19-29.
3. Armati PJ, Pollard JD, Gatenby P. 1990. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13:106-116.
4. Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. 1995. A role for CD95 ligand in preventing graft rejection. Nature 377:630-632.
5. Bergsteinsdottir K, Kingston A, Mirsky R, Jessen KR. 1991. Rat Schwann cells produce interleukin-1. J Neuroimmunol 34:15-23.
6. Bolin LM, Verity N, Silver JE, Shooter EM, Abrams JS. 1995. Interleukin-6 production by Schwann cells and induction in sciatic nerve injury. J Neurochem 64:850-858.
7. Brockes JP, Fields KL, Raff MC. 1979. Studies on cultured Schwann cells. I. Establishment of purified populations from cultures of peripheral nerve. Brain Res 165:105-118.
8. Choi C, Park JY, Lee J, Lim J-H, Shin E-C, Ahn YS, Kim C-H, Kim S-J, Kim J-D, Choi IS, Choi I-H. 1999. Fas ligand and Fas are expressed constitutively in human Astrocytes and the expression increases with IL-1, IL-6, TNF-α, or IFN-γ. J Immunol 162:889-1895.
9. Constable AL, Armati PJ, Toyka KV, Hartung HP. 1994. Production of prostanoids by Lewis rat Schwann cells in vitro. Brain Res 635:75-80.
10. Constable AL, Armati PJ, Hartung HP. 1999. DMSO induction of leucotriene LTC4 by Lewis rat Schwann cells. J Neurol Sci 162: 120-126.
11. Conti G, Scarpini E, Rostami A, Livraghi S, Baron PL, Pleasure D, Scarlato G. 1998. Schwann cell undergoes apoptosis during experimental allergic neuritis (EAN). J Neurol Sci 161:29-35.
12. De Maria R, Testi R. 1998. Fas-FasL interactions: a common pathogenetic mechanism in organ-specific autoimmunity. Immunol Today 19:121-125.
13. Gao BY, Herndon JM, Zhang H, Griffith TS, Ferguson TA. 1998. Antiinflammatory effects of CD95 ligand (FasL)-induced apoptosis. J Exp Med 188:887-896.
14. Gold R, Toyka KV, Hartung HP. 1995. Synergistic effect of gamma-IFN and TNF-α on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165:65-70.
15. Gold R, Zielasek J, Kiefer R, Toyka KV, Hartung HP. 1996. Secretion of nitrite by Schwann cells and its effect on T-cell activation in vitro. Cell Immunol 168:69-77.
16. Gold R, Hartung HP, Lassmann H. 1997. T-cell apoptosis in autoimmune diseases: termination of inflammation in the nervous system and other sites with specialized immune-defense mechanisms. Trends Neurosci 20:399-404.
17. Griffith TS, Ferguson TA. 1997. The role of FasL-induced apoptosis in immune privilege. Immunol Today 18:240-244.
18. Hartung HP, Stoll G, Toyka KV. 1993. Immune reactions in the peripheral nervous system. In: Dyck PJ, Thomas PK, Griffin JW, Low PA, Poduslo JF, editors. Peripheral neuropathy. Philadelphia: WB Saunders. p 418-444.
19. Hughes RAC. 1990. Guillain-Barré syndrome. 1st ed. London: Springer. p 49-81.
20. Husain N, Chiocca EA, Rainov N, Louis DN, Zervas NT. 1998. Co-expression of Fas and Fas ligand in malignant glial tumors and cell lines. Acta Neuropathol (Berl) 95:287-290.
21. Kingston AE, Bergsteinsdottir K, Jessen KR, Van der Meide PH, Colston MJ, Mirsky R. 1989. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) class II determinants without interferon-gamma pretreatment: synergistic effects of interferon-gamma and tumor necrosis factor on MHC class II induction. Eur J Immunol 19:177-183.
22. Knipping E, Debatin KM, Stricker K, Heilig B, Eder A, Krammer PH. 1995. Identification of soluble APO-1 in supernatants of human B- and T-cell lines and increased serum levels in B- and T-cell leukemias. Blood 85:1562-1569.
23. Krammer PH, Dhein J, Walczak H, Behrmann I, Mariani S, Matiba B, Fath M, Daniel PT, Knipping E, Westendorp MO, Stricker K, Bäumler C, Hellbardt S, Germer M, Peter ME, Debatin K-M. 1994. The role of APO-1-mediated apoptosis in the immune system. Immunol Rev 142:175-191.
24. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophageT4. Nature 227:680-685.
25. Mariani SM, Matiba B, Baumler C, Krammer PH. 1995. Regulation of cell surface APO-1/Fas (CD95) ligand expression by metalloproteases. Eur J Immunol 25:2303-2307.
26. Nagata S. 1994. Fas and Fas ligand: a death factor and its receptor. Adv Immunol 57:129-144.
27. Nagata S. 1996. Fas ligand and immune evasion. Nature Med 2:1306-1307.
28. Nagata S. 1997. Apoptosis by death factor. Cell 88:355-365.
29. Nagata S, Golstein P. 1995. The Fas death factor. Science 267:1449-1455.
30. Oehm A, Behrmann I, Falk W, Pawlita M, Maier G, Klas C, Li-Weber M, Richards S, Dhein J, Trauth BC. 1992. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. Sequence identity with the Fas antigen. J Biol Chem 267:10709-10715.
31. Ohtsuki T, Micallef M, Kohno K, Tanimoto T, Ikeda M, Kurimoto M. 1997. Interleukin 18 enhances Fas ligand expression and induces apoptosis in Fas-expressing human myelomonocytic KG-1 cells. Anticancer Res 17:3253-3258.
32. Risau W, Engelhardt B, Wekerle H. 1990. Immune functions of the blood-brain barrier: incomplete presentation of protein (auto-(antigens by rat brain microvascular endothelium in vitro. J Cell Biol 110:1757-1766.
33. Suda T, Takahashi T, Golstein P, Nagata S. 1993. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family. Cell 75:1169-1178.
34. Sun D, Whitaker JN, Cao LG, Han Q, Sun SH, Coleclough C, Mountz J, Zhou T. 1998. Cell death mediated by Fas-FasL interaction between glial cells and MBP-reactive T cells. J Neurosci Res 52: 458-467.
35. Towbin H, Staehelin T, Gordon J. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 76:4350-4354.
36. Wekerle H, Schwab M, Linington C, Meyermann R. 1986. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 16:1551-1557.
37. Weller M, Frei K, Groscurth P, Krammer PH, Yonekawa Y, Fontana A. 1994. Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines. J Clin Invest 94:954-964.
38. Weller M, Kleihus P, Dichgans J, Ohgaki H. 1998. CD95 ligand: lethal weapon against malignant glioma? Brain Pathol 8:285-293.
39. Zettl UK, Gold R, Toyka KV, Hartung HP. 1996. In situ demonstration of T cell activation and elimination in the peripheral nervous system during experimental autoimmune neuritis in the Lewis rat. Acta Neuropathol (Berl) 91:360-367.